Stock Research for XOMA

XOMA

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

XOMA Stock Chart & Research Data

The XOMA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the XOMA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


XOMA Due diligence Resources & Stock Charts

The XOMA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View XOMA Detailed Price Forecast - CNN Money CNN View XOMA Detailed Summary - Google Finance
Yahoo View XOMA Detailed Summary - Yahoo! Finance Zacks View XOMA Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View XOMA Trends & Analysis - Trade-Ideas Barrons View XOMA Major Holders - Barrons
NASDAQ View XOMA Call Transcripts - NASDAQ Seeking View XOMA Breaking News & Analysis - Seeking Alpha
Spotlight View XOMA Annual Report - CompanySpotlight.com OTC Report View XOMA OTC Short Report - OTCShortReport.com
TradeKing View XOMA Fundamentals - TradeKing Charts View XOMA SEC Filings - Bar Chart
WSJ View Historical Prices for XOMA - The WSJ Morningstar View Performance/Total Return for XOMA - Morningstar
MarketWatch View the Analyst Estimates for XOMA - MarketWatch CNBC View the Earnings History for XOMA - CNBC
StockMarketWatch View the XOMA Earnings - StockMarketWatch MacroAxis View XOMA Buy or Sell Recommendations - MacroAxis
Bullish View the XOMA Bullish Patterns - American Bulls Short Pains View XOMA Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View XOMA Stock Mentions - StockTwits PennyStocks View XOMA Stock Mentions - PennyStockTweets
Twitter View XOMA Stock Mentions - Twitter Invest Hub View XOMA Investment Forum News - Investor Hub
Yahoo View XOMA Stock Mentions - Yahoo! Message Board Seeking Alpha View XOMA Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for XOMA - SECform4.com Insider Cow View Insider Transactions for XOMA - Insider Cow
CNBC View XOMA Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for XOMA - OTC Markets
Yahoo View Insider Transactions for XOMA - Yahoo! Finance NASDAQ View Institutional Holdings for XOMA - NASDAQ


Stock Charts

FinViz View XOMA Stock Insight & Charts - FinViz.com StockCharts View XOMA Investment Charts - StockCharts.com
BarChart View XOMA Stock Overview & Charts - BarChart Trading View View XOMA User Generated Charts - Trading View




Latest Financial News for XOMA


XOMA Acquires Royalty Interest Position from Agenus on Seven Assets Being Developed by Merck and Incyte
Posted on Friday September 21, 2018

EMERYVILLE, Calif., Sept. 21, 2018-- XOMA Corporation, announced today that for $15.0 million, it has acquired from Agenus a partial interest position in the rights to potential milestone and royalty payments ...


XOMA to Present at the H. C. Wainwright 20th Annual Global Investment Conference
Posted on Tuesday August 28, 2018

XOMA Corporation (XOMA), a pioneer in the discovery, development and licensing of therapeutic antibodies, announced today its Chief Executive Officer, Jim Neal, will present at the H. C. Wainwright 20th Annual Global Investment Conference on Wednesday, September 5, 2018, at 11:40-12:05PM ET in New York, New York. XOMA has built a significant portfolio of products that are licensed to and being developed by other biotechnology and pharmaceutical companies.  The Company’s portfolio of partner-funded programs spans multiple stages of the drug development process and across various therapeutic areas.  Many of these licenses are the result of XOMA’s pioneering efforts in the discovery and development of antibody therapeutics.  The Company’s royalty-aggregator business model includes acquiring additional licenses to partner-funded programs.  XOMA’s license portfolio has the potential to generate significant milestone payments and royalty revenue in the future.  For more information, visit www.xoma.com.


XOMA to Present at the 2018 Wedbush PacGrow Healthcare Conference and the 2018 Southern California Investor Conference
Posted on Thursday August 09, 2018

XOMA has built a significant portfolio of products that are licensed to and being developed by other biotechnology and pharmaceutical companies.  The Company’s portfolio of partner-funded programs spans multiple stages of the drug development process and across various therapeutic areas.  Many of these licenses are the result of XOMA’s pioneering efforts in the discovery and development of antibody therapeutics.  The Company’s royalty-aggregator business model includes acquiring additional licenses to partner-funded programs.  XOMA’s license portfolio has the potential to generate significant milestone payments and royalty revenue in the future.  For more information, visit www.xoma.com.


Xoma (XOMA) Reports Q2 Loss, Lags Revenue Estimates
Posted on Tuesday August 07, 2018

Xoma (XOMA) delivered earnings and revenue surprises of -15.00% and -50.60%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?


Stock Market & Investing Books

Enter a stock symbol to view the stock details.